NIFTY 50

Axis Capital is upbeat on domestic pharma stocks

Updated : September 06, 2018 16:57:27 IST

Broking house Axis capital said they are upbeat on domestic pharma stocks which are more of a consumption kind of play.

Domestic pharma stocks' valuations are reasonable and demand looks to be sustainable, said Kashyap Pujara of Axis Capital.

Structurally, rupee depreciation is a tailwind for IT and pharma space but one has to see if they have sustainable demand as key drivers and not just rupee depreciation as a tailwind, he said.

On higher crude prices and depreciating rupee Pujara said these are clear macro challenges for the market.

"One needs to keep in mind that we are in an inflation targeting regime and it up to the Reserve Bank of India (RBI) on how they rein-in the inflation expectations, which would over time let rupee come back to its fair level," he said.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you